Paul A. Wagner - Jan 17, 2022 Form 4 Insider Report for Forte Biosciences, Inc. (FBRX)

Role
CEO, President, Secretary and Chair of the Board, Director
Signature
/s/ Paul A. Wagner, Ph.D
Stock symbol
FBRX
Transactions as of
Jan 17, 2022
Transactions value $
$0
Form type
4
Date filed
1/18/2022, 07:26 PM
Previous filing
Sep 8, 2021
Next filing
May 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FBRX Stock Option (right to buy) Award $0 +300K $0.00 300K Jan 17, 2022 Common Stock 300K $1.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person's Continuous Service (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the total shares subject to the option shall vest every month thereafter such that all shares shall be fully vested on the four year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean January 17, 2022.

Remarks:

CEO, President, Secretary and Chair of the Board